A new review published on Aug. 6 examines the relationship between obesity and biological aging, outlining how excess body fat may not only increase chronic disease risk but also accelerate the aging process. The review explores overlapping molecular mechanisms that connect obesity and aging, as well as the potential for anti-obesity therapies to slow down aging and reduce age-related diseases.
According to the review, multiple biological hallmarks drive aging, including chronic inflammation, telomere shortening, mitochondrial dysfunction, genomic instability, impaired protein homeostasis, stem cell exhaustion, and altered nutrient sensing. Obesity appears to promote many of these same changes. The authors say this suggests obesity acts as an accelerator of biological aging rather than simply increasing disease risk independently.
Chronic low-grade inflammation is identified as one of the strongest links between obesity and aging. The review explains that excess adipose tissue becomes infiltrated by immune cells producing inflammatory cytokines. This leads to persistent systemic inflammation associated with insulin resistance, metabolic dysfunction, cardiovascular disease, and tissue damage. The authors say this inflammatory state closely resembles "inflammaging," a phenomenon observed during normal aging.
The review further describes several additional mechanisms through which obesity may accelerate aging: telomere depletion, epigenetic alterations, mitochondrial dysfunction, stem cell exhaustion, genomic instability, protein homeostasis disruption, cellular senescence, and gut microbiome dysbiosis. A summary diagram in the publication illustrates these ten interconnected processes and emphasizes how obesity affects many of the same pathways that naturally deteriorate with age.
Evidence is highlighted showing that weight loss interventions can partially reverse some of these changes related to biological aging. Lifestyle approaches such as calorie restriction and exercise—alongside pharmacological treatments or bariatric surgery—have been linked with improvements in metabolic function and reductions in markers associated with aging. Modern anti-obesity medications discussed include liraglutide, semaglutide, tirzepatide, and orlistat for their potential roles in improving healthy lifespan by reducing inflammation and oxidative stress while enhancing mitochondrial function.
